Medicine and Dentistry
Adrenal Insufficiency
100%
Maturity Onset Diabetes of the Young
66%
Hydrocortisone
66%
Vitamin D
50%
Insulin Dependent Diabetes Mellitus
50%
Immunocompetent Cell
44%
Macrophage
38%
Immunoassay
36%
Neonatal Intensive Care Unit
33%
Vitamin D Deficiency
33%
Hypovitaminosis D
33%
Oxidative Stress
33%
Central Nervous System
33%
Insulin Allergy
33%
Renin Angiotensin Aldosterone System
33%
Cancer Treatment
33%
Childhood Cancer
33%
Hematopoietic Cell
33%
Allergic Response
27%
Diseases
27%
Adipose Tissue
22%
Insulin Resistance
22%
Endocrine Disease
22%
Metabolic Disorder
22%
Monoclonal Antibody
20%
Therapy Effect
16%
Tetracosactide
16%
Steroid Treatment
16%
Steroidogenesis
16%
Sodium Retention
16%
Sympathetic Tone
16%
Steroid Therapy
16%
Neonate
16%
Chronic Inflammation
16%
Microglia
16%
Sympathetic Nervous System
16%
Antihypertensive Therapy
16%
Immune Cell Infiltration
16%
Hypertension
16%
Kidney Injury
16%
Adaptive Immunity
16%
Cardiovascular Mortality
16%
Endothelial Function
16%
Blood Vessel Tone
16%
Adrenal Gland
16%
Adverse Effect
16%
Steroid Hormone
16%
Liquid Chromatography-Mass Spectrometry
13%
Polyclonal Antibody
13%
Quality of Life
11%
Keyphrases
Adrenal Insufficiency
100%
Cortisol Assay
66%
Type 1 Diabetes Mellitus (T1DM)
66%
Type 2 Diabetes Mellitus (T2DM)
66%
Type I Diabetes
66%
Obesity
44%
Vitamin D
40%
Steroid Use
37%
Serum Cortisol
33%
Immunoassay
33%
Antenatal Steroids
33%
Hematopoietic Stem Cells
33%
Insulin Deficiency
33%
Steroid Taper
33%
Vitamin D Deficiency
33%
Hypertension
33%
Childhood Cancer Survivors
33%
Cancer Treatment
33%
Health Outcomes
22%
Endocrine Disorders
22%
Cortisol
21%
Monoclonal Antibody
21%
Immune Cells
17%
Adrenal Gland Cortex
16%
Postnatal Assessment
16%
Steroid Therapy
16%
Postnatal Treatment
16%
Stress Dose
16%
Fetal Adrenal
16%
Therapeutic Role
16%
Preterm Infants
16%
Adrenal Development
16%
Steroid Hormones
16%
Adrenal Steroidogenesis
16%
Neonate
16%
Fetus
16%
Steroid Treatment
16%
Exogenous Steroids
16%
Therapeutic Effect
16%
Adverse Effects
16%
Polyclonal Antibody
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
Insulin Resistance
13%
MEF2
13%
Peroxisome Proliferator-activated Receptor-γ coactivator-1α (PGC-1α)
13%
JARID2
13%
Area under the Curve
11%
Quality of Life
11%
Renin-angiotensin System
11%
Central Nervous System
11%
